|Bid||60.10 x 1500|
|Ask||61.50 x 30000|
|Day's range||78.59 - 80.49|
|52-week range||56.75 - 81.54|
|PE ratio (TTM)||21.16|
|Dividend & yield||2.03 (2.37%)|
|1y target est||N/A|
Johnson & Johnson was hit with a $110 million jury decision in favor of a woman who said talc in the company’s baby powder gave her ovarian cancer, the latest—and largest—verdict yet in the litigation ...
Johnson & Johnson was ordered by a St. Louis jury to pay more than $110 million to a Virginia woman who blamed her ovarian cancer on the company’s talcum products.
Q1 2017 Imerys SA Earnings Call